ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993

In Congress: DOD Cancer Research Programs Increased; Senate Passes NIH Funding Bill; Porter Won’t Seek Re-election

October 22, 1999